- Home
- VNDA vs QTRX Comparison
VNDA vs QTRX Comparison
Compare VNDA & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- QTRX
- Stock Information
- Founded
- VNDA 2002
- QTRX 2007
- Country
- VNDA United States
- QTRX United States
- Employees
- VNDA N/A
- QTRX N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- VNDA Health Care
- QTRX Industrials
- Exchange
- VNDA Nasdaq
- QTRX Nasdaq
- Market Cap
- VNDA 237.9M
- QTRX 201.7M
- IPO Year
- VNDA 2006
- QTRX 2017
- Fundamental
- Price
- VNDA $4.33
- QTRX $5.15
- Analyst Decision
- VNDA Strong Buy
- QTRX Strong Buy
- Analyst Count
- VNDA 2
- QTRX 4
- Target Price
- VNDA $16.50
- QTRX $18.25
- AVG Volume (30 Days)
- VNDA 754.6K
- QTRX 764.8K
- Earning Date
- VNDA 05-07-2025
- QTRX 05-06-2025
- Dividend Yield
- VNDA N/A
- QTRX N/A
- EPS Growth
- VNDA N/A
- QTRX N/A
- EPS
- VNDA N/A
- QTRX N/A
- Revenue
- VNDA $198,772,000.00
- QTRX $137,421,000.00
- Revenue This Year
- VNDA $14.36
- QTRX $5.22
- Revenue Next Year
- VNDA $44.53
- QTRX $15.31
- P/E Ratio
- VNDA N/A
- QTRX N/A
- Revenue Growth
- VNDA 3.18
- QTRX 12.30
- 52 Week Low
- VNDA $3.85
- QTRX $4.67
- 52 Week High
- VNDA $6.75
- QTRX $19.18
- Technical
- Relative Strength Index (RSI)
- VNDA 43.42
- QTRX 36.29
- Support Level
- VNDA $4.27
- QTRX $5.03
- Resistance Level
- VNDA $4.46
- QTRX $5.73
- Average True Range (ATR)
- VNDA 0.22
- QTRX 0.52
- MACD
- VNDA 0.01
- QTRX -0.02
- Stochastic Oscillator
- VNDA 54.55
- QTRX 21.43
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.